China / Paxlovid's Exclusion from National Insurance; CanSino's mRNA Booster Trial; WuXi/GSK T-cell Deal; Biocytogen/Hansoh Antibody Collab
A roundup of some of the biggest healthcare and pharma news from China including the exclusion of Pfizer’s Paxlovid from the country’s national insurance coverage, CanSino’s promising mRNA booster trial…